UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO

RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2018

 

Commission File Number: 001-38396

 

BIOFRONTERA AG

(Registrant’s name / Translation of registrant’s name into English)

 

Hemmelrather Weg 201, D-51377 Leverkusen Germany

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [X] Form:40-F [  ]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): N/A

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): N/A

 

 

 

 
 

 

EXHIBITS

 

Exhibit Number   Description
     
99.1  

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BIOFRONTERA AG
   
  By: /s/ Hermann Lübbert
  Name: Hermann Lübbert
  Title: Chief Executive Officer

 

  By: /s/ Thomas Schaffer
  Name: Thomas Schaffer
  Title: Chief Financial Officer

 

Date: November 22, 2018

 

 
 

 

 
Biofrontera AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

22.11.2018

 

The issuer is solely responsible for the content of this announcement.

 

 

 

1. Details of the person discharging managerial responsibilities / person closely associated

 

a) Name

Title:  
First name: Christoph
Last name(s): Dünwald

 

2. Reason for the notification

 

a) Position / status

Position: Member of the managing body

 

b) Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a) Name

Biofrontera AG

 

b) LEI

391200D6GFSVFGFQTL13 

 

4. Details of the transaction(s)

 

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: DE0006046113

 

b) Nature of the transaction

Acquisition

 

c) Price(s) and volume(s)

Price(s) Volume(s)
5.345 EUR 10690.00 EUR

 

d) Aggregated information

Price Aggregated volume
5.345 EUR 10690.00 EUR

 

e) Date of the transaction

2018-11-21; UTC+1

 

f) Place of the transaction

Outside a trading venue

 

 

 

22.11.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

 

Archive at www.dgap.de

 

 

 

Language: English
Company: Biofrontera AG
  Hemmelrather Weg 201
  51377 Leverkusen
  Germany
Internet: www.biofrontera.com